Ferenc Viktória EP-képviselő
We stand for Hungarian patients and pharmaceutical industry players in the European Parliament!
2026. 07. 07.
The upcoming European Biotech Act will be one of the most significant EU regulations in the healthcare sector in the coming years. In line with this, the Fidesz-KDNP delegation to the European Parliament has submitted a comprehensive package of amendments to the proposal.
In this context, Fidesz MEP Viktória Ferenc, a member of the European Parliament’s Committee on Public Health, emphasized: “Ensuring medicine supply for Hungarian and European citizens is our primary task. To achieve this, we must make Europe an attractive investment destination once again.” András Gyürk, Fidesz MEP and member of the Patriots group, stated: “As a patriotic Hungarian representative, it is our duty to stand up for Hungarian industry players as well. Our proposals aim to ensure that high value-added, high-skill biotechnology manufacturing activities remain in Hungary and continue to generate significant added value for the Hungarian economy.”
Regarding the draft legislation, Viktória Ferenc declared: “In recent years, the European biotechnology sector has fallen into a competitive disadvantage on the global market. We must bring investments back to Europe. One suitable way to do this is to increase the number of clinical trials — an area where Hungary was previously a major player. The ultimate goal of our amendments is to guarantee Hungarian people’s access to affordable medicines.”
András Gyürk highlighted: “Another key objective of our amendment proposals was to support Hungarian pharmaceutical industry players. There can be no stable supply without a strong domestic industry. In the face of intensifying international competition, it is a fundamental national interest that high-skill biotechnology manufacturing activities and the investments underpinning them are carried out and remain in Hungary. The Commission’s proposal would have undermined this on several points, and we have worked to amend those provisions.”
Strasbourg, July 7, 2026